Facetten
Zugriff
Einrichtung
Medientyp
- Text 5
Karte
Erscheinungsjahr
Autor/in
- Kretzschmar, Albrecht
- Goekkurt, Eray 3
- Ettrich, Thomas 2
- Hofheinz, Ralf-Dieter 2
- Stein, Alexander 2
- alle zeigen
Sprache
- Englisch 5
5 Einträge gefunden
-
Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Randomized PANAMA Trial (AIO KRK 0212)
- Modest, Dominik Paul
- Karthaus, Meinolf
- Fruehauf, Stefan
- Graeven, Ullrich
- Müller, Lothar
- König, Alexander Otto
- Fischer von Weikersthal, Ludwig
-
FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2-Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group
- Hofheinz, Ralf-Dieter
- Merx, Kirsten
- Haag, Georg M
- Springfeld, Christoph
- Ettrich, Thomas
- Borchert, Kersten
- Kretzschmar, Albrecht
-
Adding cetuximab to paclitaxel and carboplatin for first-line treatment of carcinoma of unknown primary (CUP): results of the Phase 2 AIO trial PACET-CUP
- Folprecht, Gunnar
- Trautmann, Karolin
- Stein, Alexander
- Huebner, Gerdt
- Stahl, Michael
- Kasper, Stefan
- Kretzschmar, Albrecht
-
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217)
- Tintelnot, Joseph
- Goekkurt, Eray
- Binder, Mascha
- Thuss-Patience, Peter
- Lorenzen, Sylvie
- Knorrenschild, Jorge Riera
- Kretzschmar, Albrecht
-
Capecitabine and bevacizumab for non-resectable metastatic colorectal cancer patients: final results from phase II AIO KRK 0105 trial
- Stein, Alexander
- Kretzschmar, Albrecht
- Behringer, Dirk
- Wolff, Thomas
- Zimber, Joachim
- Hegewisch-Becker, Susanna
- Kettner, Erika